Abstract: Provided herein are pharmaceutical compositions, kits comprising pharmaceutical compositions, methods of treating disease, and methods of making compositions and kits described herein. The pharmaceutical compositions described herein are powdery pharmaceutical compositions. The powdery pharmaceutical compositions herein can contain particles that are encapsulated with multiple layers of material.

Abstract: Provided herein are pharmaceutical compositions, kits comprising pharmaceutical compositions, methods of treating disease, and methods of making compositions and kits described herein. The pharmaceutical compositions described herein are powdery pharmaceutical compositions. The powdery pharmaceutical compositions herein can contain particles that are encapsulated with multiple layers of material.

Abstract: Provided herein are pharmaceutical compositions, kits comprising pharmaceutical compositions, methods of treating and preventing disease, and methods of making compositions and kits described herein. The pharmaceutical compositions described herein are powdery pharmaceutical compositions. The powdery pharmaceutical compositions described herein can contain cellular material and can be microencapsulated to increase preservation of the cellular material. The powdery pharmaceutical compositions can be administered by numerous methods, such as by inhalation administration or oral administration.

Abstract: Provided herein are pharmaceutical compositions, kits comprising pharmaceutical compositions, methods of treating disease, and methods of making compositions and kits described herein. The pharmaceutical compositions described herein are powdery pharmaceutical compositions. The powdery pharmaceutical compositions may be administered by an inhaler device described herein. The powdery pharmaceutical compositions may be administered by gummies described herein.

Abstract: Provided herein are pharmaceutical compositions, kits comprising pharmaceutical compositions, methods of treating disease, and methods of making compositions and kits described herein. The pharmaceutical compositions described herein are powdery pharmaceutical compositions. The powdery pharmaceutical compositions may be administered by an inhaler device described herein. The powdery pharmaceutical compositions may be administered by gummies described herein.

Abstract: Provided herein are pharmaceutical compositions, kits comprising pharmaceutical compositions, methods of treating disease, and methods of making compositions and kits described herein. The pharmaceutical compositions described herein are powdery pharmaceutical compositions. The powdery pharmaceutical compositions may be administered by an inhaler device described herein. The powdery pharmaceutical compositions can comprise encapsulated epinephrine or encapsulated insulin.

Abstract: Provided herein are pharmaceutical compositions, kits comprising pharmaceutical compositions, methods of treating and preventing disease, and methods of making compositions and kits described herein. The pharmaceutical compositions described herein are powdery pharmaceutical compositions. The powdery pharmaceutical compositions can be administered by an inhaler device described herein.

Abstract: Provided herein are pharmaceutical or dietary supplement compositions, kits comprising pharmaceutical or dietary supplement compositions, methods of treating and preventing disease, and methods of making compositions and kits described herein. The pharmaceutical or dietary supplement composition compositions described herein can be administered orally. The pharmaceutical or dietary supplement compositions can be administered by a capsule described herein.

Abstract: Provided herein are pharmaceutical compositions, kits comprising pharmaceutical compositions, methods of treating and preventing disease, and methods of making compositions and kits described herein. The pharmaceutical compositions described herein are powdery pharmaceutical compositions. The powdery pharmaceutical compositions can be administered by an inhaler device described herein.

Abstract: A method of restoring a low cell voltage of a fuel cell in a fuel cell system to a normal cell voltage without reducing a total power output level of the fuel cell system is disclosed. The method includes operating the fuel cell system at a selected total power output level, monitoring a cell voltage of the fuel cell, detecting a low cell voltage of the fuel cell, maintaining the selected total power output level of the fuel cell system and restoring the fuel cell from the low cell voltage to the normal cell voltage by increasing flow of a gas to the fuel cell from a baseline stoichiometry to an elevated stoichiometry.

Abstract: A method for operating a hybrid vehicle and a hybrid vehicle 10 which operates in accordance with the method. Particularly, the hybrid vehicle 10 includes a pair of torque generators 12, 14 which provide torque by moving in dissimilar directions as the hybrid vehicle 10 is started and stopped, thereby reducing inertia related noise and vibration.